Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs United Airlines Holdings Inc (UAL) Price & Performance

Nuwellis IncTrade
United Airlines Holdings IncTrade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs United Airlines Holdings Inc — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while United Airlines Holdings Inc trades at $105.98 (market cap $34.87B). The key difference: United Airlines Holdings Inc is far larger — about 15850× Nuwellis Inc's market cap, and United Airlines Holdings Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and United Airlines Holdings Inc for 46 Days on average.

NUWEUAL
Market Cap
$2.20M$34.87B
Volume
121,5446,329,678
Sector
HealthIndustrials
52-Week High
$146.65$136.11
52-Week Low
$0.68$85.21
Typical Hold Time
26 Days46 Days
Enterprise Value
-$1.52M$51.90B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

United Airlines Holdings Inc

United Airlines (UAL) trades at $110.17, down 1.53% on the day, with a bearish technical signal from moving averages. The stock shows strong fundamentals with a low P/E of 10.32 and consistent earnings beats, including Q2 2026 EPS of $1.99 versus $1.88 expected. Revenue growth has climbed from $45.0B in 2022 to $59.1B in 2025, with net income margin improving to 5.67%. Recent news highlights aggressive customer acquisition efforts targeting Delta's premium flyers.

The outlook is mixed: analyst consensus is strongly bullish with a $158.10 price target and no sell ratings, but technical indicators and rising fuel costs pose near-term risks. Earnings sustainability and market share gains from competitor targeting present upside, while debt levels and operational volatility remain challenges for shareholder value.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUWE
40% Buy60% Sell
Avg holding period · 26 Days
UAL
0% Buy100% Sell
Avg holding period · 46 Days

Top news

Latest headlines on both assets

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →

About United Airlines Holdings Inc

United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.

Read more on UAL →